Table 1.
Nr | Sex | Age (yrs)a | Focus of infection | IgG anti-phase I titrea,b | IgG anti-phase II titrea,b | PCR serum/ plasmaa | PCR tissue | Duration of antibiotic treatment (months)c |
---|---|---|---|---|---|---|---|---|
1 | Male | 30 | Vascular graft | 65536 | 65536 | Pos | n.a. | 0 |
2 | Male | 66 | Aortic valve | 131072 | 131072 | Pos | Pos | 1 |
3 | Male | 64 | Aortic aneurysm | 8192 | 8192 | Neg | Pos | 2 |
4 | Male | 46 | Vascular graft | 65536 | 131072 | Pos | n.a. | 7 |
5 | Female | 64 | Aortic aneurysm | 8192 | 8192 | Pos | n.a. | 18 |
6 | Male | 72 | Vascular graft | 16384 | 8192 | Neg | Pos | 9 |
7 | Male | 74 | Aortic aneurysm | 65536 | 32768 | Neg | Pos | 4 |
8 | Female | 54 | Vascular graft | 4096 | 4096 | Neg | Pos | 24 |
9 | Male | 79 | Prosthetic aortic valve | 4096 | 4096 | Pos | n.a. | 20 |
10 | Male | 58 | Mitral valve | 4096 | 8192 | Pos | Pos | 6 |
11 | Male | 67 | Vascular graft | 4096 | 4096 | Neg | Pos | 20 |
12 | Female | 65 | Prosthetic aortic biovalve | 8192 | 16384 | Pos | n.a. | 8 |
13 | Male | 71 | Vascular graft | 2048 | 4096 | Pos | Pos | 35 |
14 | Male | 59 | Vascular graft | 16384 | 8192 | Pos | Pos | 29 |
15 | Male | 74 | Vascular/Spondylodiscitis | 8192 | 8192 | Neg | Pos | 4 |
n.a., not available; aat the moment of diagnosis of chronic Q fever; bas measured with immunofluorescence assay (IFA, Focus Diagnostics); cat the moment of first blood sample for this study.